Cargando…

The role of insulin-like growth factor-1 in development of coronary no-reflow and severity of coronary artery disease in patients with acute myocardial infarction

INTRODUCTION: Insulin-like growth factor-1 (IGF-1) has atheroprotective effects via reduction in oxidative stress, cellular apoptosis, pro-inflammatory signaling, and endothelial dysfunction. AIM: We hypothesized that low levels of IGF-1 may be associated with the severity and extent of coronary art...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akturk, Ibrahim Faruk, Yalcin, Ahmet Arif, Biyik, Ismail, Caglar, Nihan Turhan, Isiksacan, Nilgun, Sarikamis, Cetin, Uzun, Fatih, Celik, Omer, Caglar, Ilker Murat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2014
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007291/ https://www.ncbi.nlm.nih.gov/pubmed/24799921 http://dx.doi.org/10.5114/pwki.2014.41460

Ejemplares similares

Can thrombectomy and catheters used increase angiographically visible distal embolization in ST elevation myocardial infarction?
por: Sarikamis, Cetin, et al.
Publicado: (2016)

Presepsin (sCD14-ST): could it be a novel marker for the diagnosis of ST elevation myocardial infarction?
por: Caglar, Fatma Nihan Turhan, et al.
Publicado: (2017)

Left ventricular steal syndrome caused by multiple plexiform coronary artery fistulae: case report, literature review and treatment
por: Biyik, İsmail, et al.
Publicado: (2016)

Association between soluble lectin-like oxidized low-density lipoprotein receptor 1 levels and coronary slow flow phenomenon
por: Caglar, Ilker Murat, et al.
Publicado: (2016)

Role of insulin-like growth factor 1 in stent thrombosis under effective dual antiplatelet therapy
por: Yalcin, Ahmet Arif, et al.
Publicado: (2014)

Serum Presepsin Levels Are Not Elevated in Patients with Controlled Hypertension
por: Biyik, Ismail, et al.
Publicado: (2018)

Immunosuppressive therapy induced coronary vasospasm and acute myocardial infarction in a patient undergoing new renal transplantation
por: Biyik, Ismail, et al.
Publicado: (2015)

The correlation between plasma human neutrophil peptide 1-3 levels and severity of coronary artery disease
por: Ungan, Ismail, et al.
Publicado: (2016)

Is there any association between vitamin D levels and isolated coronary artery ectasia?
por: Ciftci, Serkan, et al.
Publicado: (2016)

The effect of postoperative positive end-expiratory pressure on postoperative bleeding after off-pump coronary artery bypass grafting
por: Yildiz, Yahya, et al.
Publicado: (2014)

Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are associated with cryptogenic stroke in patients with patent foramen ovale
por: Caglar, Fatma Nihan Turhan, et al.
Publicado: (2020)

Kounis Syndrome together with Myocardial Bridging Leading to Acute Myocardial Infarction at Young Age
por: Caglar, Ilker Murat, et al.
Publicado: (2011)

Antiplatelet resistance and the role of associated variables in stable patients treated with stenting
por: Uzun, Fatih, et al.
Publicado: (2015)

Does contrast media volume affect long-term survival in patients with chronic kidney disease?
por: Biyik, Ismail, et al.
Publicado: (2017)

Lipidomic Predictors of Coronary No-Reflow
por: Surendran, Arun, et al.
Publicado: (2023)

The Predictors of Asymptomatic Cerebral Embolism After Carotid Artery Stenting
por: Güner, Ahmet, et al.
Publicado: (2022)

Congenital absence of the left circumflex coronary artery and an unusually dominant course of the right coronary artery
por: BASKURT, MURAT, et al.
Publicado: (2010)

Value of coronary artery calcium score to predict severity or complexity of coronary artery disease
por: Gökdeniz, Tayyar, et al.
Publicado: (2014)

Effects of streptokinase on reflow in rescue percutaneous coronary intervention
por: Sanatkar, Masoud, et al.
Publicado: (2013)

Relation of hemoglobin level to no-reflow in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention
por: Yaylak, Barış, et al.
Publicado: (2018)

No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction
por: Gupta, Sanjiv, et al.
Publicado: (2016)

Capillary pericytes mediate coronary no-reflow after myocardial ischaemia
por: O'Farrell, Fergus M, et al.
Publicado: (2017)

Non-pharmaco, non-invasive management of coronary no-reflow phenomenon
por: Sinha, Santosh Kumar, et al.
Publicado: (2020)

Serum fibrinopeptide A is increased in patients with acute coronary syndrome
por: Yilmaz, Ahmet Seyda, et al.
Publicado: (2023)

Coronary accordion effect mimicking coronary dissection
por: Cagliyan, Caglar Emre, et al.
Publicado: (2013)

Coronary artery bypass grafting in a patient with gout arthritis
por: Ugurlucan, Murat, et al.
Publicado: (2012)

Usefulness of the platelet-to-lymphocyte ratio in predicting long-term cardiovascular mortality in patients with peripheral arterial occlusive disease
por: Uzun, Fatih, et al.
Publicado: (2017)

A rare complication of percutaneous coronary intervention: Coronary pseudoaneurysm formation
por: Çelik, Oğuzhan, et al.
Publicado: (2017)

Shock Index on Admission Is Associated with Coronary Slow/No Reflow in Patients with Acute Myocardial Infarction Undergoing Emergent Percutaneous Coronary Intervention
por: Wang, Qingcheng, et al.
Publicado: (2019)

Predictors and outcome of no-reflow post primary percutaneous coronary intervention for ST elevation myocardial infarction
por: Mazhar, Jawad, et al.
Publicado: (2015)

Frailty Significantly Associated with a Risk for Mid-term Outcomes in Elderly Chronic Coronary Syndrome Patients: a Prospective Study
por: Ozmen, Caglar, et al.
Publicado: (2020)

Spontaneous Coronary Artery Dissection in a Male Patient with Takayasu's Arteritis and Antiphospholipid Antibody Syndrome
por: Gerede, Demet Menekşe, et al.
Publicado: (2013)

Coronary sinus dilatation is a sign of impaired right ventricular function in patients with heart failure
por: Çakıcı, Musa, et al.
Publicado: (2015)

The Elevated Soluble ST2 Predicts No-Reflow Phenomenon in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Somuncu, Mustafa Umut, et al.
Publicado: (2019)

A Practical Method for No-Reflow Treatment
por: Cetin, Mustafa, et al.
Publicado: (2016)

Plasma calprotectin was associated with platelet activation and no-reflow phenomenon in acute coronary syndrome
por: Song, Nian-Peng, et al.
Publicado: (2020)

The SALINE Technique for the Treatment of the No-Reflow Phenomenon during Percutaneous Coronary Intervention in STEMI
por: Grancini, Luca, et al.
Publicado: (2023)

Coronary No-Reflow after Primary Percutaneous Coronary Intervention—Current Knowledge on Pathophysiology, Diagnosis, Clinical Impact and Therapy
por: Ndrepepa, Gjin, et al.
Publicado: (2023)

Using an Artificial Neural Network to Predict Coronary Microvascular Obstruction (No-Reflow Phenomenon) during Percutaneous Coronary Interventions in Patients with Myocardial Infarction
por: Frolov, A.A., et al.
Publicado: (2021)

Percutaneous Cardiopulmonary Support in Refractory No-Reflow with Cardiogenic Shock after Coronary Stenting in Acute Myocardial Infarction
por: Son, Jung-Woo, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_j35eo0ad7k5ubefmgfmktm336g